PT946538E - Derivados de indano ou de di-hidroindole - Google Patents
Derivados de indano ou de di-hidroindoleInfo
- Publication number
- PT946538E PT946538E PT97949999T PT97949999T PT946538E PT 946538 E PT946538 E PT 946538E PT 97949999 T PT97949999 T PT 97949999T PT 97949999 T PT97949999 T PT 97949999T PT 946538 E PT946538 E PT 946538E
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- optionally substituted
- hydroindole
- indano
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK146996 | 1996-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT946538E true PT946538E (pt) | 2003-12-31 |
Family
ID=8105168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97949999T PT946538E (pt) | 1996-12-20 | 1997-12-19 | Derivados de indano ou de di-hidroindole |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6331544B1 (pt) |
| EP (1) | EP0946538B1 (pt) |
| JP (1) | JP2001506657A (pt) |
| AT (1) | ATE246683T1 (pt) |
| AU (1) | AU5311098A (pt) |
| CA (1) | CA2275299C (pt) |
| DE (1) | DE69724000T2 (pt) |
| DK (1) | DK0946538T3 (pt) |
| ES (1) | ES2205267T3 (pt) |
| PT (1) | PT946538E (pt) |
| WO (1) | WO1998028290A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999005140A1 (en) * | 1997-07-25 | 1999-02-04 | H. Lundbeck A/S | Indole and 2,3-dihydroindole derivatives, their preparation and use |
| MXPA02004554A (es) * | 1999-11-08 | 2004-09-10 | Wyeth Corp | N-aril-(homopiperazinil)-ciclohexil aminas como transportadores de 5-ht. |
| CA2501781A1 (en) * | 2002-10-22 | 2004-05-06 | Drugabuse Sciences S.A.S. | Treatment of cognitive impairment using a selective dopamine d1 receptor agonist |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2692264B1 (fr) | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| ZA954689B (en) | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
-
1997
- 1997-12-19 ES ES97949999T patent/ES2205267T3/es not_active Expired - Lifetime
- 1997-12-19 WO PCT/DK1997/000588 patent/WO1998028290A1/en active IP Right Grant
- 1997-12-19 AU AU53110/98A patent/AU5311098A/en not_active Abandoned
- 1997-12-19 DK DK97949999T patent/DK0946538T3/da active
- 1997-12-19 DE DE69724000T patent/DE69724000T2/de not_active Expired - Fee Related
- 1997-12-19 CA CA002275299A patent/CA2275299C/en not_active Expired - Fee Related
- 1997-12-19 EP EP97949999A patent/EP0946538B1/en not_active Expired - Lifetime
- 1997-12-19 US US09/331,557 patent/US6331544B1/en not_active Expired - Fee Related
- 1997-12-19 PT PT97949999T patent/PT946538E/pt unknown
- 1997-12-19 JP JP52826398A patent/JP2001506657A/ja not_active Ceased
- 1997-12-19 AT AT97949999T patent/ATE246683T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0946538A1 (en) | 1999-10-06 |
| DK0946538T3 (da) | 2003-11-03 |
| CA2275299A1 (en) | 1998-07-02 |
| CA2275299C (en) | 2003-12-16 |
| ES2205267T3 (es) | 2004-05-01 |
| US6331544B1 (en) | 2001-12-18 |
| DE69724000T2 (de) | 2004-07-22 |
| JP2001506657A (ja) | 2001-05-22 |
| DE69724000D1 (de) | 2003-09-11 |
| AU5311098A (en) | 1998-07-17 |
| EP0946538B1 (en) | 2003-08-06 |
| WO1998028290A1 (en) | 1998-07-02 |
| ATE246683T1 (de) | 2003-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69318854T2 (de) | Spiroazacyclischderivate als substanz p antagonisten | |
| EA199700156A1 (ru) | Производные индола как антагонисты рецептора 5-нт | |
| PT641328E (pt) | Derivados aza-biciclicos em ponte como antagonistas da substancia p | |
| DE69725171D1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| WO2002085925A3 (en) | Melanocortin receptor ligands | |
| DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| ATE256671T1 (de) | 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate | |
| ATE247639T1 (de) | Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden | |
| ES2163506T3 (es) | Derivados de bencimidazolona con actividad dopaminergica central. | |
| CA2241845A1 (en) | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity | |
| PT946538E (pt) | Derivados de indano ou de di-hidroindole | |
| DK0845988T3 (da) | Hidtil ukendte kondenserede isoquinoliner som dopaminreceptorligander | |
| HK1047099B (zh) | 選擇性保護漿果赤霉素衍生物的方法及其在合成塔三烷中的應用 | |
| NO962620L (no) | Nye mellomprodukter for syntese av L-aspartyl-D--aminoalkanoyl-(S)-N--alkylbenzylamider anvendbare son kunstige sötningsmidler | |
| UA81595C2 (en) | Process for the purification of carboxaldehyde | |
| ATE243695T1 (de) | 5-bicycloindolverbindungen | |
| TR200402685T4 (tr) | Merkezi sinir sistemi üzerine etki eden siklobüta-indol karboksamid türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler. |